Pamukcu Rifat — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Pamukcu Rifat has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Pamukcu Rifat is a corporate director who serves on the board of Aprea Therapeutics, Inc. as of the June 17, 2026 SEC filing. Publicly available biographical information about Rifat within SEC disclosures is limited; the filing context identifies her solely as a director for Aprea Therapeutics with no additional biographical details provided in that context. Note that name ordering can vary in sources (e.g., Rifat Pamukcu).
Pamukcu Rifat is a corporate director who serves on the board of Aprea Therapeutics, Inc. as of the June 17, 2026 SEC filing. Publicly available biographical information about Rifat within SEC disclosures is limited; the filing context identifies her solely as a director for Aprea Therapeutics with no additional biographical details provided in that context. Note that name orde…
How many SEC Form 4 filings has Pamukcu Rifat submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Pamukcu Rifat's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
